Pneumonia

What is Pneumonia?

Pneumonia is an infection that inflames the air sacs (alveoli) in one or both lungs. The air sacs may fill with fluid or pus, leading to symptoms such as coughing, fever, chills, and difficulty breathing. Pneumonia can be caused by various organisms, including bacteria, viruses, and fungi.

Types of Pneumonia

1. Bacterial Pneumonia

2. Viral Pneumonia

3. Fungal Pneumonia

4. Aspiration Pneumonia

Common Symptoms of Pneumonia

Causes and Risk Factors

Diagnosis

Treatment Options

Prevention Strategies

Complications of Pneumonia


References & Research

Historical Background

Pneumonia has been recognized since antiquity, with Hippocrates describing it around 400 BCE as a disease "named by the ancients." In 1881, Carl Friedländer and Albert Fränkel independently identified the pneumococcus bacterium as the primary cause of bacterial pneumonia, laying the groundwork for understanding its microbiology and eventually leading to antibiotic treatment and vaccine development.

Key Research Papers

  1. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371(17):1619-1628.
  2. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the ATS and IDSA. Am J Respir Crit Care Med. 2019;200(7):e45-e67.
  3. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults (CDC EPIC Study). N Engl J Med. 2015;373(5):415-427.
  4. Torres A, Cilloniz C, Niederman MS, et al. Pneumonia. Nat Rev Dis Primers. 2021;7(1):25.
  5. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the IDSA and ATS. Clin Infect Dis. 2016;63(5):e61-e111.
  6. Postma DF, van Werkhoven CH, van Elden LJ, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372(14):1312-1323.
  7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia (PSI/PORT Score). N Engl J Med. 1997;336(4):243-250.
  8. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study (CURB-65). Thorax. 2003;58(5):377-382.
  9. Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults (CAPiTA). N Engl J Med. 2015;372(12):1114-1125.
  10. GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections. Lancet Infect Dis. 2018;18(11):1191-1210.
  11. Self WH, Semler MW, Leither LM, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19. JAMA. 2020;324(21):2165-2176.
  12. Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J Med. 2014;370(6):543-551.

Back to Table of Contents